The Microbiome Composition in Women With Recurring Intrahepatic Cholestasis of Pregnancy (ICP)
NCT05151913 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 105
Last updated 2021-12-09
Summary
This is an exploratory non-therapeutic study to study the microbiome patterns during pregnancy in women with ICP in order to identify specific bacterial strains for further product development.
Conditions
- Intrahepatic Cholestasis of Pregnancy
Interventions
- OTHER
-
Exploratory
Fecal microbiome
Sponsors & Collaborators
-
Skane University Hospital
collaborator OTHER -
Stockholm South General Hospital
collaborator OTHER -
MetaboGen AB
lead INDUSTRY
Principal Investigators
-
Helena Strevens, MD, PhD · Skane University Hospital, Sweden
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-02-14
- Primary Completion
- 2019-10-14
- Completion
- 2019-10-14
Countries
- Sweden
Study Locations
More Related Trials
-
Agreement and Reliability of Transient Elastography
NCT05686785 ·Status: RECRUITING
-
Prevention of Graft Reinfection After Liver Transplantation With Anti HCV Monoclonal Antibodies Identified in Chronically Infected Patients or in Patients With Resolved Hepatitis C
NCT00638144 ·Status: UNKNOWN
-
Prediction of Multidrug-resistant Bacterial Infection in Patients with Cirrhosis
NCT05641025 ·Status: COMPLETED
-
Specific Biomarkers of Immune-mediated Hepatitis Secondary to Immune Checkpoint Inhibitors
NCT06470997 ·Status: RECRUITING
-
Anti-E1E2 Antibodies (D32.10 Epitope-binding Antibodies) and HCV Triple Therapy
NCT02877199 ·Status: COMPLETED
-
A Cross-sectional Study on the Association of Peptidoglycan Fragments Derived From Gut Microbiota With Alcohol Liver Disease
NCT07284862 ·Status: COMPLETED
-
Gene Expression in Liver Allograft Rejection and Recurrent Hepatitis C
NCT01428700 ·Status: COMPLETED
-
Data Collection and Identification of Infection-responsible Bacterial Resistances in Cirrhotic Patients
NCT03965260 ·Status: COMPLETED
-
FGL2/Fibroleukin and Hepatitis C Virus Recurrence Post Liver Transplantation
NCT00701272 ·Status: UNKNOWN
-
Assessment of the Predictive Value of Fecal Calprotectin for the Outcome of Severe Alcoholic Hepatitis
NCT02808663 ·Status: COMPLETED ·Phase: NA
-
Secondary Sclerosing Cholangitis in Critically Ill Patients
NCT02545309 ·Status: ACTIVE_NOT_RECRUITING
-
Helicobacter Pylori and Acute Alcohol Induced Pancreatitis
NCT00490386 ·Status: COMPLETED
-
Study IL- 35 Level and Fibronectin Type Ⅲ Domain Containing Protein 5 \ Irsin (FNDC5 rs3480) Gene Variations in Chronic Hepatitis B.
NCT06023745 ·Status: UNKNOWN
-
Cytokines and the Risk of Infection in Liver Cirrhosis
NCT00857181 ·Status: TERMINATED
-
Albumin Modifications as Early Biomarkers of Chronic Liver Diseases
NCT06318949 ·Status: RECRUITING ·Phase: NA
-
Cell Bound Complement Activation Proteins as Markers of Liver Injury
NCT01025531 ·Status: WITHDRAWN
-
Liver Cirrhosis Network Cohort Study
NCT05740358 ·Status: ACTIVE_NOT_RECRUITING
-
Gut Mycobiome Profile in Alcoholic Liver Disease.
NCT05793190 ·Status: UNKNOWN
-
Microbiome Translocation in Different Circulatory Compartments in Decompensated Cirrhosis
NCT04195724 ·Status: UNKNOWN ·Phase: NA
-
Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease
NCT05669677 ·Status: COMPLETED
-
Dose Effect Relationship of MTX and IBD
NCT03531593 ·Status: COMPLETED
-
Secondary Sclerosis Cholangitis Prospective
NCT03566797 ·Status: RECRUITING
-
Understanding the Role of Oral Microbiota in Behçet's Disease (BEHCETBIOT)
NCT04959435 ·Status: COMPLETED
-
Hyperbilirubinemia in Acute Appendicitis as a Predictor of Perforation
NCT00528138 ·Status: COMPLETED
-
Evaluating the Role of Immune Responses in the Emergence of Protease Inhibitor Mutations
NCT01517529 ·Status: COMPLETED